SFRP4 linked to impaired glucose tolerance, T2DM

August 1, 2016

(HealthDay)—Secreted frizzled-related protein 4 (SFRP4) is associated with impaired glucose tolerance (IGT) and type 2 diabetes (T2D), according to a report published online July 6 in Diabetes Care.

Kaviya Anand, from the Madras Diabetes Research Foundation in Chennai, India, and colleagues reported on the systemic levels of SFRP4 and its correlation with insulin resistance and β-cell dysfunction in 100 individuals with normal glucose tolerance (NGT), 60 with IGT, and 100 with T2D.

"These findings suggest that elevated SFRP4 may be a good marker of β-cell dysfunction and insulin resistance," the authors write. "Longitudinal studies with serial measurements of SFRP4 need to be done at different stages of insulin resistance, IGT, and T2D to understand the precise pathophysiological mechanisms involved."

Related Stories

(HealthDay)—A genetic score for insulin resistance is associated with lower body mass index (BMI) and with incident type 2 diabetes (T2D) even among individuals of normal weight, according to a study published online June ...

(HealthDay)—The correlation between sleep-disordered breathing (SDB) and glucose metabolism varies for rapid eye movement (REM) sleep and non-REM sleep, according to a study published in the Nov. 1 issue of the American ...

When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who ...

Recommended for you

A UT Southwestern study reveals the hormone glucagon's importance to the development of insulin resistance and cardiac dysfunction during Type 2 diabetes, presenting opportunities to develop new therapies for diabetic diseases ...

A drug commonly used to control high blood pressure may also help prevent the onset of type 1 diabetes in up to 60 percent of those at risk for the disease, according to researchers at the University of Colorado Anschutz ...

Treating obese mice with catestatin (CST), a peptide naturally occurring in the body, showed significant improvement in glucose and insulin tolerance and reduced body weight, report University of California San Diego School ...

0 comments

Please sign in to add a comment.
Registration is free, and takes less than a minute.
Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.